ArticleFrontiers in veterinary science2025
Molecular characteristics of a potentially novel BVDV (
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine viral diarrhea virus (BVDV) is commonly detected in biological products such as tissues and serum. This study identified BVDV contamination in a commercially available fetal bovine serum (FBS) sample. To determine whether the detected virus was infectious or merely genetic material, the FBS was inoculated into Madin-Darby bovine kidney (MDBK) cells. Following six serial passages, both indirect immunofluorescence assay results and electron microscopic visualization of viral particles confirmed the presence of infectious BVDV. The isolated strain, designated BI-2023, had a complete genome length of 12,273 nucleotides. Comparative sequence analysis showed that the 5' untranslated region (UTR) and full genome of BI-2023 shared 87.4-97.1% and 92.4-95.2% nucleotide identity, respectively, with reference strains of BVDV1 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.